Serum Adipokine Levels in Patients With Ankylosing Spondylitis and Their Relationship to Clinical Parameters and Radiographic Spinal ProgressionARTHRITIS & RHEUMATOLOGYIF10.92015-02-2568PREAI
Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritisANNALS OF THE RHEUMATIC DISEASESIF20.62014-12-0167PREAI
Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritisANNALS OF THE RHEUMATIC DISEASESIF20.62014-09-0166PREAI
ELEVATED LBP LEVELS AND IN VIVO ACTIVATION OF MONOCYTES AS POTENTIAL INDICATORS OF BACTERIAL TRANSLOCATION IN AXIAL SPONDYLOARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PRE
USTEKINUMAB TREATMENT IN ANKYLOSING SPONDYLITS (AS) PATIENTS DOES NOT MODULATE EFFECTOR CD4+T CELL FREQUENCIES INCLUDING TH17 CELLSANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
Macrophages Accumulate in the Gut Mucosa of Untreated HIV-infected PatientsJOURNAL OF INFECTIOUS DISEASESIF4.52013-10-1676OAAI
PREDICTIVE AND PROTECTIVE ROLE OF ADIPOKINES IN RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH ANKYLOSING SPONDYLITISANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI
ELEVATED SERUM LEVELS OF SCLEROSTIN AND PERIOSTIN PROTECT AGAINST SYNDESMOPHYTE FORMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND HIGH ACTIVITY OF SYSTEMIC INFLAMMATIONANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI
PREDICTION OF RADIOGRAPHIC SPINAL PROGRESSION USING BIOMARKERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO ARE AT HIGH RISK FOR PROGRESSIONANNALS OF THE RHEUMATIC DISEASESIF20.62012-06-010PREAI